文献速递头颈外科咽喉与嗓音

1188例Tis-T2声门癌经口激光显微手术的长期肿瘤学结局

Long-term Oncologic Outcomes of 1188 Tis-T2 Glottic Cancers Treated by Transoral Laser Microsurgery.
PubMed 文献 · Otolaryngol Head Neck Surg · 2021-01-05

单中心回顾性队列研究纳入1988至2018年意大利Brescia大学耳鼻咽喉头颈外科收治的1188例Tis-T2声门鳞状细胞癌患者,均接受CO2经口激光显微手术(CO2 TOLMS)。10年和20年疾病特异性生存率分别为97.6%和96.3%,器官保留率分别为94.7%和93%。91%患者仅需CO2 TOLMS,复发后挽救性CO2 TOLMS可获得良好生存与器官保留。

要点

  • CO2 TOLMS治疗早期声门癌10年DSS达97.6%,20年达96.3%。
  • 10年和20年器官保留率分别为94.7%和93%。
  • 超过2次CO2 TOLMS手术与更差器官保留率显著相关。

核心结论

  • CO2 TOLMS是早期声门鳞状细胞癌的长期有效治疗策略,复发后挽救性CO2 TOLMS可获得最佳DSS和OP结果。

研究设计与样本

  • 单中心回顾性队列研究,纳入1988至2018年意大利Brescia大学耳鼻咽喉头颈外科收治的1188例Tis-T2声门鳞状细胞癌患者,均接受CO2 TOLMS。

主要发现

  • 10年和20年DSS率分别为97.6%和96.3%,10年和20年OP率分别为94.7%和93%。
  • 随访期间91%患者仅接受CO2 TOLMS治疗,其余需要辅助治疗。
  • 接受1次、2次或超过2次CO2 TOLMS手术的患者DSS无显著差异,但超过2次手术者OP率显著更差。

关键数值与推荐

  • T分期分布:Tis 124例(10%),T1a 646例(54%),T1b 172例(15%),T2 246例(21%)。
  • 男女比例11.2:1,平均年龄64岁(范围31-95岁)。

临床怎么用

  • 支持CO2 TOLMS作为Tis-T2声门鳞状细胞癌的长期治疗选择,反复手术需关注器官保留率下降。

局限性

  • 单中心回顾性研究设计。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate long-term disease-specific survival (DSS) and organ preservation (OP) rates in patients affected by Tis-T2 glottic squamous cell carcinoma (SCC) treated by carbon dioxide transoral laser microsurgery (CO2 TOLMS). STUDY DESIGN: Single-center retrospective cohort study. SETTING: Tertiary academic hospital. METHODS: The study included patients treated by CO2 TOLMS for Tis-T2 glottic SCC at the Department of Otorhinolaryngology-Head and Neck Surgery of the University of Brescia, Italy, from 1988 to 2018. The male:female ratio was 11.2:1, and the mean age was 64 years (range, 31-95). T categories were distributed as follows: 124 (10%) Tis, 646 (54%) T1a, 172 (15%) T1b, and 246 (21%) T2. RESULTS: Ten- and 20-year DSS rates were 97.6% and 96.3%, respectively, and 10- and 20-year OP rates were 94.7% and 93%. During the follow-up, 91% of patients were treated by CO2 TOLMS alone, while the remaining needed adjunctive treatments. Assessing the impact of multiple sessions of CO2 TOLMS, DSS showed no significant difference in terms of patients treated by 1, 2, or >2 procedures. Conversely, patients treated by >2 sessions of CO2 TOLMS showed a significantly worse OP rate. CONCLUSIONS: Our series validates CO2 TOLMS as a long-term treatment strategy for early glottic SCC. Salvage CO2 TOLMS provided optimal results in terms of DSS and OP in patients with recurrence after previous transoral surgery.

来源:Otolaryngol Head Neck Surg,查看原文。版权归原作者所有。

引用

  1. Piazza C, Paderno A, Del Bon F, et al. Long-term Oncologic Outcomes of 1188 Tis-T2 Glottic Cancers Treated by Transoral Laser Microsurgery. Otolaryngol Head Neck Surg. 2021. PMID: 33400625. doi:10.1177/0194599820983727

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。